Tomorrow's Science For Today's Clinician
According to some models, nearly 33 million people could be killed within the first 6 months of a severe flu pandemic
Researchers made this conclusion after analyzing 14 studies undertaken in African and Asian countries, involving 17,594 participants
Researchers are now planning to conduct an in-depth study to understand the link between oxcarbazepine and the rise in fragility fractures
Dr Nikita Kohli from AIMIL Healthcare which manufactures Lukoskin said that the drug had a success rate of almost 70 percent
Researchers noted that additional studies would be needed to see whether the treatment can cause liver toxicity
The company is planning to test this drug on patients with small fiber neuropathy and trigeminal neuralgia
The lead author of the study also underlined the importance of early screening and treatment for this patient population
Researchers revealed that statins are known to possess some general anti-inflammatory capabilities
The discovery of these specific targets could open up new avenues for treating symptoms of Alzheimer’s disease
2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2) and severe acute respiratory syndrome coronavirus (SARS-CoV) are human coronaviruses (HCoVs) causing global epidemics with high morbidity and mortality. Presently, there are no effective drugs to treat 2019-nCoV.